A research team led by the University of Minnesota Medical School demonstrated that the socioeconomic status (SES) of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation (HCT). The work is published in the journal Proceedings of the National Academy of Sciences. The study examined the health outcomes of 2,005 blood cancer patients treated with HCT across 125 hospitals in the United States. The research team found cancer patients who were transplanted with cells from donors of greatest socioeconomic disadvantage experienced a 9.7% reduction in overall survival and 6.6% increase in transplant-related mortality at Read More
No comments:
Post a Comment